-
Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT
Silvia Montoto, Jurgen H. E. Kuball, Jarl Mooyaart, Artak Ghandilyan, Dilyana Georgieva, Isabel Sánchez‐Ortega, +19 more
0citations -
Race and Ethnicity As a Category Poses Challenges in Global Registries: Experience from the Waustim Project of the Worldwide Network for Blood and Marrow Transplantation, WBMT2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Race, Genetics, and Society
Nada Hamad, Hiroyuki Takamatsu, Luuk A. Gras, Linda Köster, Laurien G.A. Baaij, Anita D’Souza, +44 more
0citations -
Central Nervous System Disorders (CNSD) Following Hematopoietic Stem Cell Transplantation (HSCT): A Prospective Study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP), European Society of Blood and Marrow Transplantation (EBMT)
Martin Schmidt‐Hieber, Per T Ljungman, Nina Simone Knelange, Joanna Ewa Drozd-Sokolowska, Grzegorz Władysław Basak, Hermann Einsele, +20 more
0citations -
Current practices, organizational structures, technologies and challenges in developing atmps: A survey by dare-NL, nxtgen hightech, T2EVOLVE and ctiwp of EBMT - a gocart-coalition initiative
Anil K. Deshantri, Simone Punt, Jesús Fernandez Sojo, Sergio Querol, Zsolt Sebestyén, Carmen Sanges, +7 more
0citations -
Long-term safety and efficacy of iptacopan in patients with paroxysmal nocturnal hemoglobinuria: 4- and 5-year follow-up of patients from Phase 2 studies who entered the roll-over extension program
Antonio Maria Risitano, Camilla Frieri, Bor‐Sheng Ko, Lily Wong Lee Lee, Alexander Röth, Flore Sicre de Fontbrune, +8 more
0citations